For the quarter ended September 30, 2025, the Company reported a net loss applicable to common stockholders of $8.2 million, or ($0.13) per share, compared to a net loss applicable to common ...

Broadcast Retirement Network's Jeffrey Snyder discusses the rise in liver cancer diagnosis with Hashem El-Serag, M.D., Baylor ...

October was Liver Health Awareness Month, and Jubilee Clinical Research is still offering free liver screenings for those at ...

Significant improvements observed in secondary endpoints, including reductions in liver fat, inflammation and biomarkers of fibrosis GAITHERSBURG, Md., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc ...

Metavia, an affiliate of Dong-A ST, announced on November 11 that it presented additional analysis results from the Phase 2a clinical trial of ...

New biomarker analyses from the NAVIGATE trial demonstrated consistent antifibrotic effects of belapectin 2 mg/kgUsing established criteria for clinically meaningful worsening, a lower proportion of ...

In a second poster, spatial computational histology relying on baseline fibrosis features was used to predict response to denifanstat ...

Eligible patients in Sandwell and West Birmingham are now able to refer themselves for a scan checking the health of their liver.

Semaglutide 2.4 mg produces weight-independent liver benefits among individuals with metabolic dysfunction-associated steatohepatitis.

Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect ...

The new office will support operations and provide training for healthcare providers in India and neighboring countries.

Echosens has opened its new regional headquarters in Mumbai, India, to strengthen its presence in South Asia. The facility will support operations across the region, enhancing access to FibroScan® for ...